The US Food and Drug Administration (FDA) has granted clearance for Nipro Diagnostics’ True Metrix Air self-monitoring blood glucose system.
True Metrix Air is a device designed for people with diabetes to test blood glucose and deliver data wirelessly to a smartphone.
Nipro is the largest US manufacturer of diabetes products for the store brand market.
The device, which uses True Metrix test strips featuring Triple Sense Technology, was developed to elevate store brand product offerings that solve patient needs.
Triple Sense Technology detects, analyses and corrects for environmental and physiological variability including hematocrit and temperature with proven better accuracy.
Nipro Diagnostics president Scott Verner said: "Our new True Metrix Air self-monitoring blood glucose system is technology with reach.
"Nipro Diagnostics’ customers have a better way to deliver superior health and wellness products that empower people with diabetes and their health support network to make better decisions for a healthier life."
The launch of this product is part of the company’s strategic plan to create a model of interconnected patient health and wellness solutions that aids chronic disease management and increases patient engagement.
Nipro manufactures and distributes supplemental health and wellness products including sharps, neutraceuticals, personal care products, and dietary supplements and continues to expand its portfolio.
True Metrix Air will be available through retail, mail and distribution channels under store brands and the company’s own TRUE brand of products from the second quarter of 2015.
Image: Nipro’s True Metrix Air blood glucose meter. Photo: courtesy of Business Wire.